Showing results (231-240 of 544) with videos related to

Sort By:
Pageof 55
Vaccine: X|August 31, 2023
Low uptake of COVID-19 vaccines in Wad Medani City, Gezira State, Sudan: Hesitancy and poor accessibilityM Elmustafa, A Wedaa, Hanaa Babiker, et al.
Vaccine: X|March 29, 2021
Demographic, psychological, and experiential correlates of SARS-CoV-2 vaccination intentions in a sample of Canadian familiesChristine L Lackner, Charles H Wang
Vaccine: X|August 12, 2022
Acceptability of COVID-19 vaccines among Black immigrants living in the United StatesAdedotun Ogunbajo, Bisola O Ojikutu
Vaccine: X|August 28, 2023
Exploring Shigella vaccine priorities and preferences: Results from a mixed-methods study in low- and middle-income settingsJessica A Fleming, Nikki Gurley, Sophia Knudson, et al.
Vaccine: X|August 14, 2023
Role of leadership and incentive-based programs in addressing vaccine hesitancy in IndiaBita Afsharinia, Anjula Gurtoo
Vaccine: X|June 15, 2026
Estimating historical impacts of vaccination against influenza B/Yamagata in the United States to inform possible risks of re-emergence in the absence of vaccinationSinead E Morris, Sarabeth M Mathis, Jessie R Chung, et al.
Vaccine: X|July 6, 2022
Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized studyXavier Sáez-Llorens, Claudio Lanata, Elaine Aranguren, et al.
Vaccine: X|December 18, 2020
VANGUARD®crLyme: A next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogsRichard T Marconi, David Garcia-Tapia, Jacquelien Hoevers, et al.
Vaccine: X|December 18, 2020
Field safety study of VANGUARD®crLyme: A vaccine for the prevention of Lyme disease in dogsRichard T Marconi, Nicole Honsberger, M Teresa Winkler, et al.
Vaccine: X|August 6, 2026
Five values for COVID-19 vaccine acceptance described by racial and ethnic minoritized caregiversSonal Jain, Rohan Dayal, Jennifer Sikov, et al.
Pageof 55